Radiopaedia Helpers

small-cell-carcinoma-of-the-prostate

Strong List Colon Position

error

"T1: heterogeneous low to intermediate signal intensity"

Line 58:8 · When enboldening an intro, the colon should not be bold. 'T1: heterogeneous'

"T2: heterogeneously high signal intensity"

Line 59:8 · When enboldening an intro, the colon should not be bold. 'T2: heterogeneously'

"DWI: heterogeneous hyperintense on high b-value with moderate low signal intensity on ADC"

Line 60:8 · When enboldening an intro, the colon should not be bold. 'DWI: heterogeneous'

"DCE (Gd): avid enhancement"

Line 61:8 · When enboldening an intro, the colon should not be bold. 'DCE (Gd): avid'

Acronyms

warning

"The small cell component of immunohistochemistry stains usually expresses neuroendocrine markers as synaptophysin, neurone-specific enolase, chromogranin or CD56 ¹. About half of the tumours show positivity in thyroid transcription factor (TTF-1) ^2,3. Typical prostatic markers as the prostate-specific antigen (PSA) or P501S are only positive in about 1/6 to 1/4 of the cases ¹."

Line 28:276 · 'TTF' has no definition. Spell it out if it's unfamiliar to the audience.

Emphasis

warning

"Fusions of the TMPRSS2 and ERG genes might be found with small cell carcinomas of the prostate ^1-3. Other mutations include the N-MYC and the RB1 gene ⁴."

Line 30:19 · Italics should be used only in exceptional circumstances: 'TMPRSS2 and ERG genes might be found with small cell carcinomas of the prostate 1-3. Other mutations include the N-MYC'

Eponym Apostrophe

warning

"Cushing's syndrome"

Line 38:11 · Radiopaedia prefers the non-possessive eponym: 'Cushing's syndrome'.

EG List And

warning

"metastases to other organs than bone e.g. brain, lung or liver metastases"

Line 49:45 · An e.g. list gives selected examples, so it should not end with 'and' or 'or': 'e.g. brain, lung or'.

Headings Valid

warning

Expected headings

H1 Terminology
H1 Usage
H1 Epidemiology
H2 Risk factors
H2 Associations
H1 Clinical presentation
H2 Complications
H1 Diagnosis
H2 Diagnostic criteria
H2 Diagnostic clues
H1 Pathology
H2 Aetiology
H2 Location
H2 Classification
H2 Macroscopic appearance
H2 Microscopic appearance
H2 Immunophenotype
H2 Markers
H2 Genetics
H1 Radiographic features
H2 Plain radiograph
H2 Mammography
H2 Antenatal ultrasound
H2 Transoesophageal echocardiography
H2 Ultrasound
H2 CT
H3 Dual-energy CT
H2 Angiography (DSA)
H2 MRI
H2 CT/MRI
H2 Nuclear medicine
H3 PET-CT
H3 PET-MRI
H1 Radiology report
H1 Treatment and prognosis
H2 Complications
H1 History and etymology
H1 Differential diagnosis
H2 Clinical differential diagnosis
H1 Practical points
H1 See also

"Associations"

Line 31:1 · "Associations" is under the wrong parent heading (found under "Pathology").

"Signal characteristics"

Line 56:1 · "Signal characteristics" is not a recognised heading for this article type.

Oxford Comma

suggestion

"Due to relatively low prostate-specific antigen (PSA) levels in relation to tumour extent, tumour detection is more difficult and patients frequently present with voiding difficulties, haematuria, constitutional or neurological symptoms due to paraneoplastic syndromes or metastases. They might also be incidentally found on imaging studies ^1-4."

Line 7:196 · Use the Oxford comma in 'haematuria, constitutional or neurological'.

"Tumour markers such as CEA, CA19-9, plasma CgA, neurone-specific enolase, 5-hydroxytryptamine, bombesin or gastrin might be positive ¹."

Line 8:101 · Use the Oxford comma in 'hydroxytryptamine, bombesin or gastrin'.